Lily Yonghui Sun

Lily Yonghui Sun is an experienced medical professional currently serving as the Director and Senior Safety Physician at Idorsia Pharmaceuticals Ltd since December 2022. Prior roles include Medical Director and Senior Safety Physician at AstraZeneca from September 2020 to November 2022, as well as Safety Physician at Sobi from April 2015 to July 2019, where responsibilities focused on anti-inflammatory and anticoagulant products. Additionally, Lily Yonghui Sun held the position of International Medical Director and Safety Advisor at Novo Nordisk from August 2005 to March 2015. Educational qualifications include a PhD in Medicine from Lund University and a Master's degree in Clinical Medicine from Sun Yet-Sen University of Medical Science, along with a Doctor of Medicine degree from Sun Yet-sen University.